Dynamics of Weight Change and Glycemic Control in Patients with Type 2 Diabetes Treated with Exenatide or Insulin

被引：0
|
作者：
Paul, Sanjoy K.
Best, Jennie H.
Naughton, Margaret
Maggs, David
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [21] Weight Change and Glycemic Control After Diagnosis of Type 2 Diabetes
    Adrianne C. Feldstein
    Gregory A. Nichols
    David H. Smith
    A. Gabriela Rosales
    Nancy Perrin
    Journal of General Internal Medicine, 2008, 23 : 1339 - 1345
  • [22] Weight change and glycemic control after diagnosis of type 2 diabetes
    Feldstein, Adrianne C.
    Nichols, Gregory A.
    Smith, David H.
    Rosales, A. Gabriela
    Perrin, Nancy
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (09) : 1339 - 1345
  • [23] Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
    Hernandez-Nunez, Wellbert
    Villareal-Perez, Jesus Zacarias
    Rodriguez-Gutierrez, Rene
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1330 - 1330
  • [24] Usefulness of Exenatide Therapy in Patients With Type 2 Diabetes Under Undesirable Glycemic Control
    Yoshida, Mami
    Yamamoto, Naomune
    Saeki, Akio
    Sugino, Masakazu
    Yoshida, Shigeru
    Kuzuya, Takeshi
    Ohsawa, Nakaaki
    Hanafusa, Toshiaki
    DIABETES, 2012, 61 : A619 - A619
  • [25] Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes
    Rosenstock, Julio
    Shenouda, Sylvia K.
    Bergenstal, Richard M.
    Buse, John B.
    Glass, Leonard C.
    Heilmann, Cory R.
    Kwan, Anita Y. M.
    MacConell, Leigh A.
    Hoogwerf, Byron James
    DIABETES CARE, 2012, 35 (05) : 955 - 958
  • [26] Predictive factors of achieving the glycemic objective in patients with type 2 diabetes treated with insulin or exenatide: results of a meta-analysis
    Brodows, R.
    Milton, D.
    Salaun-Martin, C.
    Mao, J.
    Wintle, M.
    Trautmann, M.
    DIABETES & METABOLISM, 2008, 34 : A48 - A49
  • [27] Pramlintide improved glycemic control and reduced body weight in patients with type 2 diabetes treated with basal insulin (without mealtime insulin) and a thiazolidinedione
    Lorenzi, Gayle
    Frias, Juan
    Lutz, Karen
    Kesty, Nicole
    Zhang, Bei
    Kolterman, Orville
    DIABETES, 2007, 56 : A147 - A147
  • [28] Improvements in cardiovascular risk factors accompanied improved glycemic control and weight reduction in patients with type 2 diabetes treated with exenatide for 3.5y
    Kendall, David
    Blonde, Lawrence
    Mac, Susanna
    Guan, Xue-Song
    Holcombe, John
    Okerson, Ted
    Kim, Dennis
    Bhole, Deepak
    DIABETES, 2007, 56 : A149 - A149
  • [29] Weight Change, Blood Pressure, Lipids and Glycemic Control among Patients with Type 2 Diabetes
    Janghorbani, Mohsen
    Amini, Masoud
    Salehi-Marzijarani, Mohammad
    ANNALS OF NUTRITION AND METABOLISM, 2011, 58 (02) : 141 - 149
  • [30] Glycemic control, hypoglycemic therapy and subsequent weight change among type 2 diabetes patients
    Wu, Eric
    Yu, Andrew
    Birnbaum, Howard
    Semanii, Sriniva
    Fay, Madeleine
    Oglesby, Alan
    Pohl, Gerhardt
    Stockl, Karen
    Wintle, Matthew
    DIABETES, 2006, 55 : A274 - A274
12345